SV

Street Verdict

Analyst Scorecard

A record of what Jigar S. Patel said publicly, with the source. Not advice.

“Recommends buying Sun Pharma for 2-3 weeks, targeting ₹1,800 with a stop loss at ₹1,650. The stock has formed a robust base in the ₹1,650–1,680 range, coinciding with the S3 Camarilla monthly pivot, a rising trendline, and a pitchfork's lower median line, indicating a high probability of a bullish reversal.”

Jigar S. Patel’s track record (trackable calls only): 147 graded calls · 95% CI 13–25%

Sun Pharmaceutical IndustriesBullishCalled 28 Jul 2025Graded 01 Aug 2025
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

No entry price is stated, so the call starts at the first close after it was published.

Target ₹1,800, stop ₹1,650, as stated.

No time frame is stated, so it is tracked until a close reaches ₹1,800 or ₹1,650: there is no fixed window.

The stop ₹1,650 was reached on a close before the target ₹1,800. Miss.

The grader’s working: R4 TARGET_CALL: entered ₹1710.5 on 2025-07-29 (next trading session's close); stop ₹1650 breached at close ₹1629.7 on 2025-08-01. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

How it played out

How this is worked out
Target or stop first
The stop was reached on a close before the target was.
Time to target
The target was not reached on a close before the stop was.
Worst close against it
The closing price went as far as 4.72% against the call up to 1 Aug 2025, when the call was decided, measured from the entry price. Closing prices only; an intraday dip is never counted.

From the entry the grade used, on closing prices. This is a record of one past call and is not advice.

Tracking Sun Pharmaceutical Industries since this call

1-year tracking window
Read the original articleSee Jigar S. Patel’s full track record